In one case, SMAD4 mutation was present in the pre-transformed NSCLC sample, and in the other, it was gained during transformation, which was consistent with previous reports showing acquisition of rare SMAD4 mutations in patients with T-SCLC [12,75]. Here, SMAD4 is linked to non-small cell lung carcinoma.